Samuel E Navarro's Insider Trades & SAST Disclosures
Samuel E Navarro's most recent trade in Biosig Technologies Inc was a trade of 25,000 Restricted Stock Units ("RSUs") done . Disclosure was reported to the exchange on June 21, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Samuel E Navarro.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biosig Technologies Inc | Samuel E. Navarro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2021 | 25,000 | 0 | - | - | Restricted Stock Units ("RSUs") | |
| Biosig Technologies Inc | Samuel E. Navarro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2021 | 25,000 | 155,000 (0%) | 0% | - | Common Stock | |
| Biosig Technologies Inc | Samuel E. Navarro | Director | Grant, award, or other acquisition of securities at price $ 3.31 per share. | 25 May 2021 | 1,500 | 130,000 (0%) | 0% | 3.3 | 4,965 | Common Stock |
| STRATA Skin Sciences Inc | Samuel E. Navarro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.29 per share. | 09 Oct 2020 | 15,000 | 66,136 (0%) | 0% | 1.3 | 19,350 | SSKN Common Stock |
| STRATA Skin Sciences Inc | Samuel E. Navarro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2020 | 15,000 | 0 | - | - | STRATA Skin Non-Qualified Stock Option (Option to Buy) | |
| Biosig Technologies Inc | Samuel E. Navarro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2020 | 50,000 | 128,500 (0%) | 0% | 0 | Common Stock | |
| Biosig Technologies Inc | Samuel E. Navarro | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2020 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Biosig Technologies Inc | Samuel E. Navarro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 50,000 | 78,500 (0%) | 0% | 0 | Common Stock | |
| Biosig Technologies Inc | Samuel E. Navarro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2020 | 25,000 | 28,500 (0%) | 0% | - | Common Stock | |
| Biosig Technologies Inc | Samuel E. Navarro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2020 | 25,000 | 25,000 | - | - | Restricted Stock Units ("RSUs") |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges